T[he Plum Island Animal Disease Center]{.smallcaps} (PIADC) is the only laboratory in the United States authorized to work with many of the high-consequence agricultural pathogens that are not endemic to the United States. The list of biological agents used at the PIADC includes the federally regulated select agents of foot-and-mouth disease virus (FMDV), a US Department of Agriculture Tier-1 select agent, and swine vesicular disease virus (SVDV). As US federal regulations and guidance for working with these select agents evolve, the requirements for maintaining biosafety and biosecurity at high-containment laboratories must be continually reviewed and revised. Recent amendments to the Agricultural Bioterrorism Protection Act of 2002, Select Agents and Toxins Regulations (March 2017), highlight the need for high-containment laboratories working with select agents to develop site- and process-specific "validated inactivation procedures" based on pathogen biorisk level in materials after removal from containment.^[@B1]^ Furthermore, Federal Select Agent Program policy guidelines indicate that inactivation procedures must be validated based on "in-house" testing protocols and supported by efficacy data produced by the specific high-containment laboratory.^[@B2]^

Biohazard risk assessments consider pathogenicity, transmissibility, and environmental persistence of pathogens, along with the anticipated risks of potential contamination and release scenarios. Pathogens may also be ranked for resistance to physical and chemical disinfection to indicate their inherent stability and ease of inactivation.^[@B3],[@B4]^ For chemical inactivation, viral pathogens generally fall into 1 of 2 categories: the more labile large lipid-enveloped viruses, and the small nonenveloped viruses, which are more resistant to disinfectants and more environmentally persistent.^[@B3]^ FMDV and SVDV are 2 high-risk pathogens used at PIADC that fall into the latter category of small nonenveloped viruses resistant to inactivation by drying^[@B5],[@B6]^ and require validated procedures for chemical disinfection.

Homeland Security Presidential Directive 12 (HSPD-12): Policy for a Common Identification Standard for Federal Employees and Contractors (July 2015),^[@B7]^ as well as other policies,^[@B8]^ require all federal employees and contractors to use a common identification standard for secure access to government facilities and information systems. To comply with HSPD-12, the PIADC uses personal identity verification (PIV) cards, a type of US federal smart card, as a form of 2-factor authentication to access all facility computers. For a minority of PIADC users, this requires transit of PIV cards into the high-containment laboratory, where high-consequence agricultural pathogens are used, to obtain network access. The PIV cards used at PIADC are 5.5 × 8.5 cm plastic polyvinyl chloride cards with an integrated gold microchip and magnetic strip covered by a laminated coating ([Figure 1](#f1){ref-type="fig"}). The risk of PIV card contamination with high-consequence agricultural pathogens is considered to be extremely low because these pathogens are manipulated only within primary containment devices (eg, biological safety cabinets) in laboratory spaces where PIV cards are permitted. In this study, we sought to validate the PIADC procedure for decontamination of PIV cards exiting biocontainment to meet PIADC operational requirements.

![Personal identity verification card, a smart card, showing viral inoculation sites as red spots.](fig-1){#f1}

Virkon^®^ S is a commercial disinfectant registered for use against both FMDV and SVDV by the US Environmental Protection Agency (EPA),^[@B9]^ and it is marketed as a broad-spectrum on-farm disinfectant for agricultural biosecurity (Lanxess). The active chemical ingredients of Virkon^®^ S are potassium peroxymonosulphate (21.41%) and sodium chloride (1.5%) with inorganic buffers. Virkon^®^ S is the primary disinfectant employed at PIADC for decontamination in the high-containment laboratory. It is used to disinfect biological safety cabinets, work surfaces, and animal isolation rooms and as a boot dip when entering and exiting animal containment facilities. Seven commercial disinfectants are currently registered by the US EPA for use against FMDV.^[@B10]^ However, Virkon^®^ S proved to be the least corrosive, most broad-spectrum, easy-to-use, and nonhazardous chemical option to meet PIADC operational requirements. Additionally, Virkon^®^ S is the only commercial disinfectant that is registered by the US EPA for use against many other high-consequence agricultural pathogens used at PIADC, including African horse sickness virus, African swine fever virus, classical swine fever virus, and vesicular stomatitis virus.^[@B9],[@B10]^

The current PIADC biosafety protocol for transfer of small, nonporous items (eyeglasses, CDs) out of BSL-3 biocontainment requires immersion in 1% Virkon^®^ S for 30 seconds, followed by a water rinse, prior to personnel exiting via a 5-minute shower, and was the basis for this study. A 1% Virkon^®^ S solution delivers 9.75% available chlorine, similar to household bleach,^[@B9]^ and requires a minimum 10-minute contact time, per label instructions. However, for routine disinfection of personal items such as PIV cards, we sought to evaluate efficacy at shorter contact times that are more practical for high-containment laboratory operations.

The goal of these studies was to evaluate the ability of 1% Virkon^®^ S to disinfect PIV card surfaces intentionally spotted with high concentrations of both FMDV and SVDV, simulating accidental contamination of the PIV card. Studies were designed to evaluate viral inactivation under worst-case scenario parameters that included viral loads dried in the presence of an organic soil load and disinfectant solutions prepared in hard water and aged for 5 days. Relatively short disinfectant contact times were evaluated to support practical use in a laboratory environment.

Methods {#s001}
=======

Virus Stocks and Cell Lines {#s002}
---------------------------

FMDV strain A24/Cruzeiro/BRA/55 was obtained from the US Department of Homeland Security PIADC virus repository and amplified in LFBK~αVβ6~ cells (kindly supplied by M. LaRocco, US Department of Agriculture \[USDA\] Agricultural Research Service, PIADC).^[@B11],[@B12]^ SVDV strain UKG 27/72 was amplified in MVPK cells, both of which were generously provided by the USDA Animal Plant Health Inspection Service, Foreign Animal Disease Laboratory, PIADC. Cells were propagated in complete Dulbecco\'s Modified Eagle\'s medium (cDMEM, Gibco, \#12430054) supplemented with 10% fetal bovine serum, 1X antibiotic/antimycotic (Gibco, \#15240062), and 1X sodium pyruvate (Gibco, \#11360070) in T150 flasks and incubated at 37°C with 5% CO~2~. At 72 hours postinfection, cell supernatants were clarified by centrifugation, aliquoted, and stored at −70°C. The initial viral stock concentrations were 8.29 and 8.23 log~10~ TCID~50~ (median tissue culture infective dose)/mL for FMDV and SVDV, respectively.

Soil Load Preparation {#s003}
---------------------

The soil load used in the quantitative carrier test is an American Society for Testing and Materials (ASTM) standard used to represent normalized protein levels found in bodily secretions.^[@B13]^ Briefly, solutions of 5.0% yeast extract (Cole Parmer, \#BP142210), 5.0% bovine serum albumin (BSA) (Cole Parmer, \#BP6711), and 0.4% bovine mucin (Sigma, \#M3895) were prepared using sterile phosphate buffered saline (PBS) and filtered through a 0.22-μm filter under vacuum. Soil load component solutions were aliquoted as single-use portions and stored at −20°C until inoculum preparation.

Inoculum Preparation {#s004}
--------------------

The virus inoculum for each study was prepared immediately before spotting PIV cards on the morning of each test day from previously aliquoted and frozen single-use virus stocks. Briefly, virus stocks were supplemented to contain final concentrations of 0.35% yeast extract, 0.25% BSA, and 0.04% bovine mucin. To achieve this, 340 μl of the virus suspension was combined with 25-μL BSA stock, 35-μL yeast extract stock, and 100-μL bovine mucin stock, prepared as described above.

Disinfectant Preparation {#s005}
------------------------

Powdered Virkon^®^ S (Pharmacal, \#03010F) was dissolved in hard water to produce a 1% solution (pH ∼2.5). Hard water was formulated according to the EPA guidelines (SOP No. MB-30-01),^[@B14]^ and final CaCO~3~ concentrations were determined by titration with a Hach Total Hardness Test Kit (Hach \#2063600). The target hardness was 375 mg CaCO~3~/L, with an acceptable error margin of ±5-10% (338-394 ppm). Disinfectant solutions were prepared 5 days in advance of the day of testing to simulate an aged formulation consistent with current PIADC biocontainment protocols that mandate weekly preparation of Virkon^®^ S solutions.

PIV Card Inoculation {#s006}
--------------------

New, unused PIV cards were used as experimental coupon carriers. Briefly, 50 μL of either the FMDV or SVDV inocula test suspension containing the organic soil load was pipetted onto the cards at 2 locations, the gold metallic and laminate plastic surfaces ([Figure 1](#f1){ref-type="fig"}), and air-dried in a certified Class II biological safety cabinet at room temperature. Drying of the virus inoculum took approximately 1.5 hours. Virus-spotted PIV cards and controls were processed immediately after drying.

Quantitative Carrier Disinfection Assay {#s007}
---------------------------------------

The effect of contact time on PIV card disinfection was determined by immersion of PIV cards in 1% Virkon^®^ S for 1, 10, 30, or 60 seconds. Exposures consisted of dipping each card vertically using sterile plastic forceps into a 1% Virkon^®^ S solution (500 mL), followed by a 1-second dip in a sterile deionized water bath (200 mL). Individual beakers of Virkon^®^ S and water were used for each card to ensure no cross-contamination occurred. For each study, 3 positive control groups were included, as follows: (1) a TCID~50~ back-titration of the virus and soil load suspension to confirm the starting titer delivered to each card, (2) a drying control to assess the effect of drying on loss of virus infectivity, and (3) a dipping control to measure any loss of virus infectivity by physically immersing the PIV card for 60 seconds in a neutral liquid (water) without disinfectant ([Table 1](#T1){ref-type="table"}). Disinfection experiments were carried out in a certified Class II biological safety cabinet in BSL-3 containment. Two identical studies were conducted for each treatment to assess inter-assay variation. Each experimental contact time treatment group included 3 PIV card replicates per time point, and positive controls included 1 PIV card per treatment group.

###### 

Description and experimental significance of positive and negative control groups

  *Control Group*          *Description*                                                                                                             *Significance*
  ------------------------ ------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------
  Negative control         100 μL of DMEM + soil load dried on PIV card without virus; card inoculum was eluted in 10 mL media.                      Demonstrates that soil load components and PIV card are not cytotoxic to cell lines
  Back titration control   100 μL viral inoculum + soil load inoculated directly into 10 mL media, no drying.                                        Demonstrates starting titer of infectious virus inoculum prior to drying
  Drying control           100 μL viral inoculum + soil load dried on PIV card and eluted in 10 mL media.                                            Demonstrates titer of recoverable infectious virus after drying of inoculum on card surfaces
  Dipping control          100 μL viral inoculum + soil load dried on PIV card; card was immersed in water (60 seconds) and eluted in 10 mL media.   Demonstrates effect of mechanically dipping card in liquid on ability to recover virus without disinfectant exposure

Viral Recovery {#s008}
--------------

Following immersion in Virkon^®^ S and a water rinse, PIV cards were placed into individual sterile plastic boxes containing 10 mL of DMEM +2% FBS to neutralize any remaining Virkon^®^ S and shaken for 10 minutes on an orbital shaker at room temperature to elute any remaining viral inoculum. FMDV eluates were serially diluted 10-fold from 10^−1^ to 10^−6^ in cDMEM and plated in replicates of 8 wells per dilution onto 96-well microtiter plates seeded with adherent monolayers of LFBK~αVβ6~ cells. In order to increase the limit of detection (LOD), SVDV eluates were serially diluted from 10^0^ to 10^−5^ and plated onto adherent MVPK cell monolayers in either 96-well (Study 1) or 48-well (Study 2) plates. After 3 days of incubation, cell monolayers were scored for virus cytopathic effects (CPE), and the TCID~50~ of each viral sample was calculated via the Reed-Muench method.^[@B15]^ The LOD was 2.0 log~10~ for the FMDV studies, and 1.0 and 1.3 log~10~ for the first and second SVDV studies, respectively. The assay LOD value was used to calculate the average recovery for samples with no CPE. In the repeat study for each virus, supernatants from all CPE-negative samples were incubated on the appropriate cell line for 2 additional blind passes (72 hours each) in 96-well plates.

During methods development, it was shown that DMEM +2% FBS effectively neutralized the chemical activity of Virkon^®^ S at the assay use-dilution of 50 μL chemical:10 mL neutralizer and did not induce cytotoxicity on the cell lines used (data not shown). Additionally, swabbing the surface of PIV cards resulted in recovery of \<1% of the virus recovered from PIV cards after elution in DMEM, suggesting that the majority of infectious virus was eluted into the media during shaking and did not remain stuck to the card (data not shown).

Statistical Analyses {#s009}
--------------------

Mean, standard deviation, and 2-tailed *t*-tests were calculated using Excel 2013 (Microsoft).

Results {#s010}
=======

Card Functionality {#s011}
------------------

Prior to conducting the decontamination studies of FMDV and SVDV on PIV cards, the physical integrity and functionality of PIV cards was evaluated after exposure to Virkon^®^ S. No adverse effects on PIV card structure or function were found after immersion into 2% Virkon^®^ S for up to 10 hours (data not shown).

Recovery from Positive Control Groups {#s012}
-------------------------------------

After combination with the soil load components, the average starting titers of undried FMDV and SVDV were 7.3 and 5.65 log~10~ TCID~50~/mL, respectively ([Figure 2](#f2){ref-type="fig"}). Drying of the viral inocula onto card surfaces resulted in average losses in titer of 0.2 (from 7.3 to 7.1) and 0.4 (from 5.6 to 5.2) log~10~ for FMDV and SVDV ([Figure 2](#f2){ref-type="fig"}). Thus, recovery of dried FMDV and SVDV from PIV card surfaces was sufficient to determine virus inactivation values for FMDV ([Table 2](#T2){ref-type="table"}) and SVDV ([Table 3](#T3){ref-type="table"}) using CPE-based TCID~50~ log-reduction calculations. The physical process of dipping cards contaminated with dried inoculum in water for 60 seconds resulted in average titer reductions of 1.6 and 1.3 log~10~ for FMDV and SVDV, respectively ([Figure 2](#f2){ref-type="fig"}). Starting titers of both FMDV and SVDV were sufficient (\>10^−4^ log~10~ TCID~50~/mL) to meet the EPA virucidal efficacy requirements for chemical disinfectant registration testing in which a 4-log~10~ reduction in infectious virus must be demonstrated.^[@B16]^ No CPE or cytotoxicity was observed in cells inoculated with eluates from negative control coupons.

![Recovery of FMDV and SVDV from positive control and Virkon^®^ S--exposed PIV cards after 1-, 10-, 30-, and 60-second contact times. Bars designate the geometric mean recovery (± standard deviation, SD) for each virus across 2 studies. For Virkon^®^ S--exposed cards, *n* = 6 replicates (3 per study), and for each control group *n* = 2 replicates (1 per study). Numbers above the bars indicate the number of PIV cards with detectable virus from 6 experimental replicates per group. Values for CPE-negative samples are reported as the assay limit of detection, which was 2.0 log~10~ TCID~50~/mL for FMDV and 1.0 and 1.3 for SVDV studies 1 and 2, respectively. ND = not done.](fig-2){#f2}

###### 

Recovery of foot-and-mouth disease virus from personal identity verification cards

  *Control*                *Study 1*   *Study 2*
  ------------------------ ----------- -----------
  Back titration control   7.3         7.3
  Drying control           6.7         7.5
  Dipping control          5.5         5.9

               *Study 1 Replicates*   *Study 2 Replicates*                            
  ------------ ---------------------- ---------------------- ------- ------- ------- -------
  1 second     6.2                    6.7                    6.7     6.6     6.6     6.0
  10 seconds   \<2.0                  \<2.0                  \<2.0   3.5     \<2.0   \<2.0
  30 seconds   \<2.0                  \<2.0                  \<2.0   \<2.0   \<2.0   \<2.0
  60 seconds   \<2.0                  \<2.0                  \<2.0   \<2.0   \<2.0   \<2.0

Values are log~10~ TCID~50~/mL. Limit of detection (LOD) = 2.0 log~10~ TCID~50~/mL.

###### 

Recovery of swine vesicular disease virus from personal identity verification cards

  *Control*                *Study 1*   *Study 2*
  ------------------------ ----------- -----------
  Back titration control   5.3         5.8
  Drying control           4.3         6.1
  Dipping control          3.7         4.1

               *Study 1 Replicates*   *Study 2 Replicates*                            
  ------------ ---------------------- ---------------------- ------- ------- ------- -------
  10 seconds   \<1.0                  2.6                    1.1     1.7     \<1.3   2.8
  30 seconds   2.7                    \<1.0                  \<1.0   \<1.3   \<1.3   \<1.3
  60 seconds   \<1.0                  \<1.0                  \<1.0   \<1.3   \<1.3   \<1.3

Values are log~10~ TCID~50~/mL. Limit of detection (LOD) = 1.0 log~10~ TCID~50~/mL (Study 1), and 1.3 log~10~ TCID~50~/mL (Study 2).

Virus Recovery After Exposure to 1% Virkon^®^ S {#s013}
-----------------------------------------------

For FMDV-spotted PIV cards, exposure to 1% Virkon^®^ S for 1 second resulted in no decrease in FMDV titer. A 10-second contact time resulted in inactivation of FMDV on 5 of 6 PIV cards, with 1 PIV card having a residual FMDV titer of 3.5 log~10~ TCID~50~/mL ([Table 2](#T2){ref-type="table"}). Contact times of 30 seconds and 60 seconds resulted in inactivation of FMDV below the assay LOD for all PIV cards ([Table 2](#T2){ref-type="table"}).

For SVDV-spotted PIV cards, an exposure time of 1 second was not tested due to the lack of inactivation in the FMDV study. A 10-second exposure resulted in SVDV inactivation on 1 of 6 PIV cards, with an average recovery of 1.74 log~10~ ([Table 3](#T3){ref-type="table"}, [Figure 2](#f2){ref-type="fig"}). A contact time of 30 seconds inactivated SVDV on 5 of 6 PIV cards, and a 60-second contact time inactivated SVDV on 6 of 6 PIV cards. All inactivation studies included 3 replicates for each treatment at each contact time.

Because inter-assay variability was not statistically significant (2-tailed *t*-test, *P* ≥ 0.4), data presented are the average of all 6 samples for a disinfectant time treatment group ([Figure 2](#f2){ref-type="fig"}). In each repeat study, CPE-negative supernatants were blind-passaged on cells twice more (72 hours each), with no additional CPE-positive wells observed for either virus at contact times of 30 and 60 seconds.

Discussion {#s014}
==========

Use of smart cards has increased in the past decade in response to increased security requirements for IT network and physical access controls. Current estimates from the Office of Management and Budget indicate that nearly 5 million PIV cards have been issued to federal employees and contractors.^[@B17]^ As the number of smart card users continues to increase to meet demands for improved security at federal, military, and hospital facilities, disinfection of card surfaces could be of interest in environments where contamination may occur.

Other options for 2-factor authentication in high-containment laboratories include use of centralized PIV card readers and computer-derived credentials. However, PIADC determined that a simple step for decontaminating PIV cards during the biocontainment exit process was the most practical option for implementation, cost, and efficacy with minimal interruption to workflow. We believe this is the first reported study validating a decontamination process for the safe removal of smart cards from a high-containment laboratory.

The use of quantitative carrier assays is a widely accepted method to determine virucidal efficacy of chemical disinfectants for virus inactivation on the surface of nonporous materials.^[@B13],[@B18]^ Our modified assay used the specific object of decontamination interest, the PIV card, as the coupon carrier and FMDV and SVDV to analyze a facility-specific biosafety process. Evaluating decontamination efficacy directly against the target pathogens used in the PIADC high-containment laboratory, compared to using viral surrogates or biological indicators that may differ in biological and physical characteristics, provided accurate and specific data to support institutional disinfection protocols that address the actual biosafety risk.

Virkon^®^ S has been reported to inactivate FMDV and SVDV in quantitative carrier tests after a 10-minute contact time.^[@B19],[@B20]^ However, little data exist regarding inactivation at shortened contact times. Our data indicate that exposure to a 5-day-old 1% Virkon^®^ S solution for at least 30 seconds resulted in complete inactivation of FMDV, whereas 60 seconds of contact with Virkon^®^ S was needed to inactivate SVDV. These contact times are significantly shorter than the 10-minute contact time recommended by EPA. Therefore, the results further validate current PIADC biosafety protocols as practical and effective.

The risk of PIV card contamination in biocontainment at PIADC is considered extremely low because of the use of engineering controls (biological safety cabinets) and other biosafety practices. This study was designed to model contamination levels well above those expected at PIADC to simulate a worst-case scenario of contamination. Although the scope of this study was limited to use of Virkon^®^ S against 2 small, nonenveloped viruses, this method provides a framework for other facilities to evaluate other disinfectants against pathogens specific to their needs. Studies designed to model worst-case contamination scenarios will ensure that institutional operational procedures effectively mitigate biorisks with confidence.

Conclusion {#s015}
==========

We developed a modified quantitative carrier test method using the specific object of interest as the coupon and target high-consequence agricultural pathogens as the test organisms, in order to validate disinfection procedures for PIADC-specific biosafety practices. We found that immersion of PIV cards in 1% Virkon^®^ S for 60 seconds effectively inactivated dried FMDV and SVDV in the presence of a soil load. Because the disinfection process was effective against viral loads many times greater than anticipated for accidental unobserved laboratory contamination, this study validated the PIADC protocol for disinfection of PIV cards exiting BSL-3 biocontainment.
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